What’s new

• Q4 consolidated operating income rose 3% year-on-year to ₹8,633 million, but EBITDA margins fell to 2.31%.
• The compression was driven by costs at the new Roha facility and disruption from the West Asia crisis.
• The year-end engineering order book stood at ₹26,433 million, with order intake up 40% over the prior year.

Why it matters

The margin story is the negative. Revenue growth is being consumed by the cost base of a new plant that is still ramping up and a geopolitical conflict that is hitting dispatches. The 40% jump in order intake is a positive signal for future revenue, but the near-term profitability is being sacrificed to build that pipeline.

What we’re watching

• How quickly Roha plant utilization improves and margins normalize.
• The timeline for resolving West Asia crisis-related disruptions to dispatches.
• Conversion of the ₹26,433 million order book into revenue and profit.

The full read

Ion Exchange's Q4 results tell a story of investment ahead of return. Revenue grew 3% year-on-year to ₹8,633 million, but EBITDA margins slid to 2.31%. The cause is clear: the new Roha plant is online and certified, but its costs are hitting the P&L now, while the export boost is still pending. The West Asia crisis is adding to the squeeze, disrupting both dispatches and input costs. On the strategic front, the commissioning of Roha and the MANN+HUMMEL technology transfer are medium-term positives. The strongest forward indicator is the order book: ₹26,433 million at year-end, with intake up 40%. The challenge is converting that book into revenue without repeating the current margin compression. For now, the company is spending to grow.

Primary source: BSE · NSE

What’s new

• Standalone net profit fell to ₹138.38 crore from ₹214.48 crore in FY25.
• Revenue grew 5.5% to ₹2,678.91 crore, failing to offset rising input costs.
• A one-time ₹14.54 crore charge for labour-code adjustments weighed on earnings.

Why it matters

The company is struggling to protect its bottom line despite top-line growth. A 15.4% drop in combined segment profit for engineering and chemicals suggests that the core business is facing significant margin pressure that goes beyond one-time accounting charges.

What we’re watching

• Whether the margin compression persists into the next fiscal year.
• Any signs of recovery in the engineering and chemicals segment profitability.
• The impact of input cost inflation on upcoming quarterly margins.

The full read

Ion Exchange (India) ended FY26 with a 35.5% drop in standalone net profit to ₹138.38 crore, even as revenue climbed 5.5% to ₹2,678.91 crore. The results reveal a clear case of margin compression, driven by rising input costs and a one-time ₹14.54 crore charge for labour-code adjustments.

Margins are under siege.

The weakness is broad-based, with the combined profit of the engineering and chemicals segments falling 15.4% year-on-year, and the March quarter was particularly difficult as net profit slid to ₹19.57 crore from ₹64.58 crore in the same period last year. While the board maintained the dividend at ₹1.25 per share, the underlying operational performance suggests that the company is struggling to pass on higher costs to its customers, leaving the open question of whether this margin squeeze is a temporary hurdle or a signal of structural challenges in the water-treatment business.

Primary source: BSE · NSE